Skip to content

California · Nonprofit

CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY

CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY (California) receives grants from 2 organizations whose IRS filings report $1,042,746 to it, the largest being NEW VENTURE FUND ($858,746). 1 of them have funded it in more than one year, and 82% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2025
$20M
Funders on record
2
Grants received
$1.0M
Net assets
$19M
1/2 repeat funderspeak grant-dependency 7%
01What it does

What California Institute for Immunology and Immunotherapy does

Mission

To harness the power of the human immune system and advanced computing technologies to create and translate scientific discoveries into next generation vaccines and therapies for prevention, control and cure of chronic diseases, enabling longer and healthier lives.

As stated on its FY2025 Form 990.

Program

  1. The institute is a medical sciences research institute dedicated to the study of the immune system and its varied roles in the pathogenesis and potential treatment of a wide variety of diseases. With a mission to deeply decode the workings of the human immune system to promote health, combat disease and prolong life, the institute was established to create a multidisciplinary medical research institute to coordinate research into the human immune system across universities and research institutions in california. The institute also plans to engage in the continuous and active conduct of medical research in collaboration with various nonprofit hospitals.

The program described on its FY2024 Form 990.

02The organization over time

The organization over time

Each line starts at 100 in 2023, so what you read is the shape rather than the size: 150 means half as much again as 2023, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20232023 Revenue 100 ($1.1M) Expenses 100 ($934k) Net assets 100 ($175k)2024 Revenue 90 ($1.0M) Expenses 49 ($462k) Net assets 407 ($713k)2025 Revenue 1804 ($20M) Expenses 170 ($1.6M) Net assets 10947 ($19M)
202320242025
Revenue (1804)Expenses (170)Net assets (10947)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2024 to 2025, from $1.0M to $20M (+1834%).

$192k
$1.0M
$20M
202320242025
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2023
2024
2025
ContributionsProgram revenueInvestmentOther

100% of CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).

This organization
Typical peer · 4,743 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 3 reported years ran a deficit.

$175k
’23
$538k
’24
$18M
’25
147
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Gary Michelson

Board chair/director

As listed on its FY2025 Form 990.

202320242025
Listed6611
Joined·+0+5
No longer listed·00
03Who funds it

Who funds it, year by year

2022 → 2023: the base narrowed from 2 funders to 1 funder, grant income fell $959k → $75k.

Funder
'22
'23
'24*
total
funders
2
1
1

1 of 2 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 82% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY leans on a few funders — its largest provides 82% of grant income and the top three 100%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY.

82%
largest funder
100%
top three
~1
effective funders

Largest funder’s share by year: 2022 90% · 2023 100% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

82% of CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $184k that is directly attributable, 100% of it comes from California funders.

CA

In-state vs out-of-state, by year

’22
’23
California out of state home

Funder states come from each funder’s own filing. $859k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY holds deeper cash reserves than three-quarters of the 2,843 health nonprofits its size.

Operating margin92% · outside the comparable range
Months of reserve147.2mo · top quartile
Revenue growth (annualized)325% · outside the comparable range

this organization peer median middle 50% of peers· 2,843 health nonprofits $10M–$100M, FY2025

Organizations like CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In California

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

0% of spending goes to programs.

Program 0%Management 100%Fundraising 0%

Governance

10
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Footprint & structure

Files a return copy in 1 state

CA

Part of a family of 1 related entity

  • California Institute of Immunology and Immunotherapy Founders LLC · partnership

Screen this organization

A dated, signed PDF of the compliance screen for CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY?
CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY (California) receives grants from 2 organizations whose IRS filings report $1,042,746 to it, the largest being NEW VENTURE FUND ($858,746). 1 of them have funded it in more than one year, and 82% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY have?
IRS filings report 2 organizations giving $1,042,746 in grants to CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY, 1 of which have funded it in more than one year.
Who is the largest funder of CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY?
NEW VENTURE FUND is the largest funder on record, with $858,746 in grants. The full list of funders is on this page.
How can an organization like CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds California Institute for Immunology and Immunotherapy →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2023–2025), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing